D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 78,900
-5,000 (-5.96%)
At close: Mar 9, 2026
D&D Pharmatech Revenue
D&D Pharmatech had revenue of 969.49M KRW in the quarter ending September 30, 2025, a decrease of -50.02%. This brings the company's revenue in the last twelve months to 8.36B, up 2.15% year-over-year. In the year 2024, D&D Pharmatech had annual revenue of 11.44B, down -38.77%.
Revenue (ttm)
8.36B
Revenue Growth
+2.15%
P/S Ratio
410.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
3,434.95B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaResearch | 496.03B |
| SK bioscience | 624.03B |
| OliX Pharmaceuticals | 10.18B |
| Hugel | 425.10B |
| Orum Therapeutics | 25.48M |
| Voronoi | 7.49B |
| Peptron | 6.19B |
| HLB Co., Ltd. | 80.73B |